Dutch Cancer Foundation (KWF) grant for Dömling
Prof. Alex Dömling, Drug Design group of GRIP, together with co-workers of the UMCG (Profs. H. Nijmans and P. Elsinga) recently was awarded a grant of approx. €840.000 by the Dutch Cancer Foundation (KWF) research and implementation programme. The project is titled: Non-invasive whole-body imaging of immune checkpoints using radiolabeled small molecules as predictive biomarker for response to therapy.
In the project, small molecules will be developed for use as PET tracers and provide proof-of-concept for their use as a predictive biomarker. The multidisciplinary team of clinicians, chemists, nuclear medicine specialists and preclinical research staff involved in this project makes us uniquely suited to develop an imaging product with near-future clinical applications.
Last modified: | 08 June 2017 1.25 p.m. |
More news
-
25 July 2025
Article highlight: New insight in how cells regulate gene activity
A new study, led by University of Groningen molecular biologist Danny Incarnato, identifies hundreds of shapeshifting regulatory RNA switches in E.coli bacteria and human cells.
-
23 July 2025
Dutch astronomers in Tenerife to test high-speed camera
Astronomers from the University of Groningen and the University of Amsterdam are on the Canary Island of Tenerife until 29 July to test a special camera to detect gamma rays emitted by extreme objects, such as supermassive black holes and supernovae....
-
17 July 2025
Veni-grants for eleven UG researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...